NIH finds bionic pancreas device maintains blood glucose levels
The National Institutes of Health (NIH) has announced that in a new multicentre clinical trial a device known as iLet bionic pancreas was found to…
Latest Deals
-
ElyptaCapital Raising $21M
-
Boston ScientificMergers & Acquisitions $230M
-
OrthoPediatricsMergers & Acquisitions $33M
-
ResMedMergers & Acquisitions $1BN
-
ElyptaCapital Raising $21M
-
Boston ScientificMergers & Acquisitions $230M
-
OrthoPediatricsMergers & Acquisitions $33M
-
ResMedMergers & Acquisitions $1BN
Deal Trends in the Medical Industry
Deals Insights dashboard tracks deal trends in the Medical industry. The dashboard provides an extensive analysis by capturing trends in terms of deal types, geographies, industry players, advisory firms, and the number of deals and their value.
In partnership with
Medical Technology’s deals dashboard tracks deal trends in the medical industry.
Medical industry deal activity by deal type — volume (last 12 months)
The chart below provides an insightful and thorough overview of deal activity in terms of deal types and the number of deals in the global medical industry over the last 12 months. It covers mergers and acquisitions (M&As), private equity and venture financing deal types.
Medical industry deal activity by deal type — value (last 12 months)
The deals insights dashboard offers an analysis on deal activity in the global medical industry in terms of deal type and value. Deal types encompassing M&As, private equity and venture financing are tracked over the last 12 months.
Mergers and acquisitions in the medical industry
Medical Technology provides an overview of M&A deal activity in the medical industry. Besides M&A deals, the dashboard tracks the leading M&A financial and legal advisors, and M&A deal activity by theme.
Medical industry M&A deal activity by region (Last 12 months)
Medical Technology’s deals dashboard tracks M&A transactions recorded in the medical industry in different regions in the last 12-month period.
Largest M&A deals in the medical industry
The following table lists details of the largest merger and acquisition deals in terms of value in the global medical industry.
| Acquirer | Target | Deal Date | Value (US$m) |
|---|---|---|---|
| Oracle | Cerner | 16 Dec 2021 | 29,600.0 |
| Baxter International | Hill-Rom Holdings | 01 Sep 2021 | 12,500.0 |
| Quidel | Ortho Clinical Diagnostics Holdings | 23 Dec 2021 | 8,000.0 |
| Bristol-Myers Squibb | Turning Point Therapeutics | 03 Jun 2022 | 4,100.0 |
| Amazon.com | 1Life Healthcare | 21 Jul 2022 | 3,900.0 |
| Stryker | Vocera Communications | 06 Jan 2022 | 3,090.0 |
| Coloplast | Atos Medical | 08 Nov 2021 | 2,492.6 |
| ICU Medical | Smiths Medical division | 08 Sep 2021 | 2,350.0 |
| Grifols | Biotest | 17 Sep 2021 | 2,159.0 |
M&A deals advisor rankings in the medical industry (2021 vs. 2020)
Medical Technology’s deals dashboard reveals top financial and legal advisors to M&A deals by both deal value and volume in the global medical industry during 2020 and 2021.
M&A financial advisor rankings in the medical industry
Medical Technology compares rankings of leading financial advisors to M&A transactions in terms of deal value and volume between 2020 and 2021.
| Advisor Name | 2021 Rank | 2020 Rank |
|---|---|---|
| The Goldman Sachs Group | 1 | 2 |
| Centerview Partners | 2 | 6 |
| Bank of America | 3 | 4 |
| Citigroup | 4 | 21 |
| J.P. Morgan Securities | 5 | 11 |
| Evercore | 6 | 3 |
| Perella Weinberg Partners | 7 | 20 |
| Barclays | 8 | 13 |
| JPMorgan Chase | 9 | 5 |
| Guggenheim Partners | 10 | 22 |
Medical Technology compares rankings of leading financial advisors to M&A transactions in terms of deal value and volume between 2020 and 2021.
| Advisor Name | 2021 Rank | 2020 Rank |
|---|---|---|
| The Goldman Sachs Group | 1 | 1 |
| JPMorgan Chase | 2 | 15 |
| Rothschild | 3 | 16 |
| J.P. Morgan Securities | 4 | 23 |
| Citigroup | 5 | 40 |
| Bank of America | 6 | 6 |
| Cowen | 7 | 9 |
| Perella Weinberg Partners | 8 | 41 |
| Morgan Stanley | 9 | 3 |
| Centerview Partners | 10 | 24 |
M&A legal advisor rankings in the medical industry
Medical Technology compares rankings of leading legal advisors to M&A transactions in terms of deal value and volume between 2020 and 2021.
| Advisor Name | 2021 Rank | 2020 Rank |
|---|---|---|
| Kirkland & Ellis | 1 | 19 |
| Fried, Frank, Harris, Shriver & Jacobson | 2 | 3 |
| Latham & Watkins | 3 | 5 |
| Sullivan & Cromwell | 4 | 15 |
| Simpson Thacher & Bartlett | 5 | 22 |
| Wachtell, Lipton, Rosen & Katz | 6 | 1 |
| Hogan Lovells International | 7 | 32 |
| Skadden, Arps, Slate, Meagher & Flom LLP & Affiliates | 8 | 9 |
| Paul, Weiss, Rifkind, Wharton & Garrison | 9 | 10 |
| Cravath, Swaine & Moore | 10 | 14 |
Medical Technology compares rankings of leading legal advisors to M&A transactions in terms of deal value and volume between 2020 and 2021.
| Advisor Name | 2021 Rank | 2020 Rank |
|---|---|---|
| Latham & Watkins | 1 | 2 |
| Kirkland & Ellis | 2 | 4 |
| Goodwin Procter | 3 | 6 |
| Jones Day | 4 | 5 |
| Ropes & Gray | 5 | 7 |
| Skadden, Arps, Slate, Meagher & Flom LLP & Affiliates | 6 | 25 |
| Cooley | 7 | 1 |
| White & Case | 8 | 26 |
| DLA Piper | 9 | 8 |
| Morgan, Lewis & Bockius | 10 | 3 |
M&A deal activity by theme in the medical industry: Last 12 months (by volume)
Medical Technology tracks the number of M&A deals by theme in the medical industry. The following chart lists top ten themes that hold the most number of deals.
Browse free reports
View MorePrivate equity deals in the medical industry
Medical Technology’s deals dashboard provides information on private equity deals data, including deals by region, top legal and financial advisors, and top deals by theme.
Private equity deal activity in the medical industry by region (Last 12 months)
Medical Technology tracks private equity deal activity in different regions of the globe over the last 12 months.
Top private equity deals in the medical industry
The following table lists details of the largest private equity deals by value in the global medical industry.
| Investor | Target | Deal Date | Value (US$m) |
|---|---|---|---|
| Bain Capital | athenahealth | 22 Nov 2021 | 17,000.0 |
| Bain Capital | Evident | 29 Aug 2022 | 3,120.1 |
| SJL Partners | Meridian Bioscience | 07 Jul 2022 | 1,540.3 |
| Ardian Holding | Biofarma | 17 Jan 2022 | 1,255.6 |
| Patient Square Capital | Hanger | 21 Jul 2022 | 1,250.0 |
| ArchiMed | Natus Medical | 18 Apr 2022 | 1,200.0 |
| EQT IX Fund | SPT Labtech | 22 Jun 2022 | 797.9 |
| BCPE Centur Investments | Classys | 27 Jan 2022 | 556.1 |
| Undisclosed | Yaneng Bioscience (Shenzhen | 08 Dec 2021 | 390.0 |
| Blackstone Life Sciences Advisors | Sanofi | 15 Mar 2022 | 328.3 |
Top private equity investors in the medical industry (last 12 months)
Medical Technology’s deals dashboard tracks top private equity investors in the medical industry over the last 12 months.
| Investor Name | Value (US$m) | No of Deals |
|---|---|---|
| Ampersand Capital Partners | N/A | 5 |
| Gilde Healthcare Partners | 104.0 | 4 |
| Armistice Capital Master Fund | 35.0 | 3 |
| BroadOak Capital Partners | 4.0 | 3 |
| Bain Capital | 20,120.1 | 2 |
| ArchiMed | 1,200.0 | 2 |
| Altaris Capital Partners | 241.0 | 2 |
| Apposite Capital | N/A | 2 |
| Arsenal Capital Partners | N/A | 2 |
| Audax Private Equity | N/A | 2 |
Private equity deals advisors in the medical industry (2021 vs. 2020)
Medical Technology monitors financial and legal advisors to private equity deals by value and volume in the global medical industry during 2020 and 2021.
Private equity financial advisor rankings in the medical industry
Medical Technology’s deals dashboard compares ranking of leading financial advisors to private equity transactions in terms of value and volume between 2020 and 2021.
| Advisor Name | 2021 Rank | 2020 Rank |
|---|---|---|
| The Goldman Sachs Group | 1 | 20 |
| Evercore | 2 | 4 |
| Bank of America | 3 | 31 |
| Morgan Stanley | 4 | 33 |
| Barclays | 5 | 11 |
| Jefferies | 6 | 8 |
| J.P. Morgan Securities | 7 | 6 |
| Ernst & Young Global | 8 | 16 |
| Deloitte Touche Tohmatsu | 9 | 19 |
| JPMorgan Chase | 10 | 13 |
Medical Technology’s deals dashboard compares ranking of leading financial advisors to private equity transactions in terms of value and volume between 2020 and 2021.
| Advisor Name | 2021 Rank | 2020 Rank |
|---|---|---|
| Jefferies | 1 | 1 |
| Evercore | 2 | 4 |
| The Goldman Sachs Group | 3 | 11 |
| Piper Sandler Companies | 4 | 5 |
| Morgan Stanley | 5 | 12 |
| Rothschild | 6 | 13 |
| Houlihan Lokey | 7 | 14 |
| KPMG International Coop | 8 | 15 |
| WBC Holdings | 9 | 16 |
| Capital One Financial | 10 | 32 |
Private equity legal advisor rankings in the medical industry
Medical Technology compares ranking of leading legal advisors to private equity transactions in terms of value and volume between 2020 and 2021.
| Advisor Name | 2021 Rank | 2020 Rank |
|---|---|---|
| Kirkland & Ellis | 1 | 15 |
| Gibson, Dunn & Crutcher | 2 | 37 |
| Dechert | 3 | 40 |
| Latham & Watkins | 4 | 2 |
| Weil, Gotshal & Manges | 5 | 5 |
| Uria Menendez Abogados SLP | 6 | 3 |
| Simpson Thacher & Bartlett | 7 | 12 |
| Willkie Farr & Gallagher | 8 | 24 |
| Morgan, Lewis & Bockius | 9 | 20 |
| Paul Hastings | 10 | 25 |
The deals dashboard compares ranking of leading legal advisors to private equity transactions in terms of value and volume between 2020 and 2021.
| Advisor Name | 2021 Rank | 2020 Rank |
|---|---|---|
| Kirkland & Ellis | 1 | 2 |
| Weil, Gotshal & Manges | 2 | 6 |
| Ropes & Gray | 3 | 4 |
| Latham & Watkins | 4 | 1 |
| Gibson, Dunn & Crutcher | 5 | 19 |
| Goodwin Procter | 6 | 7 |
| Paul Hastings | 7 | 20 |
| Dechert | 8 | 21 |
| Simpson Thacher & Bartlett | 9 | 8 |
| White & Case | 10 | 9 |
Private equity deals by theme in the medical industry: Last 12 months (by volume)
Medical Technology tracks the number of private equity deals by theme in the medical industry. The following chart lists top ten themes that hold the most number of deals in last 12 months.
Venture financing deals in the medical industry
Medical Technology’s provides an overview of venture financing deal activity in the medical industry around the globe, including deals by region, top venture financing deals and capital investors.
Venture financing deal activity in the medical industry by region (Last 12 months)
Medical Technology tracks venture financing deals recorded in the medical industry in different regions of the globe in the last 12-month period.
Top ten venture financing deals in the medical industry
The following table lists the top ten venture financing deals by value in the global medical industry.
| Investor | Target | Deal Date | Value (US$m) |
|---|---|---|---|
| Whale Rock Capital Management | Hinge Health | 29 Oct 2021 | 600.0 |
| Elevance Health | Somatus | 23 Feb 2022 | 325.0 |
| Blackstone | Medable | 26 Oct 2021 | 304.0 |
| CVS Health | Biofourmis | 26 Apr 2022 | 300.0 |
| Eventide Asset Management | Freenome | 07 Dec 2021 | 300.0 |
| Conversion Venture Capital | SmartLabs | 20 Sep 2021 | 250.0 |
| Rock Springs Capital Management | Delfi Diagnostics | 18 Jul 2022 | 225.0 |
| Novartis | Cleerly | 25 Jul 2022 | 223.0 |
| Battery Ventures | Reify Health | 21 Apr 2022 | 220.0 |
| Undisclosed | Immunai | 27 Oct 2021 | 215.0 |
Top venture capital investors in the medical industry (Last 12 months)
Medical Technology’s deals dashboard tracks top venture capital investors in the medical industry over the last 12 months.
| Investor Name | Value (US$m) | No of Deals |
|---|---|---|
| Casdin Capital | 847.9 | 14 |
| Ben Franklin Technology Partners of Southeastern Pennsylvania | N/A | 12 |
| General Catalyst Partners | 555.1 | 11 |
| BioAdvance | 13.9 | 11 |
| Northpond Ventures | 854.6 | 10 |
| Insight Partners | 615.2 | 10 |
| GV Management | 954.0 | 9 |
| Sequoia Capital China | 638.4 | 9 |
| Morningside Ventures | 454.3 | 9 |
| Qiming Venture Partners | 322.4 | 9 |
Venture financing deal activity by theme in the medical industry: Last 12 months (by volume)
Medical Technology tracks the number of venture financing deals by theme in the global medical industry. The following chart lists top ten themes that hold the most number of deals in last 12 months.
All markets data shared in the dashboard is copyright of GlobalData PLC and is subject to the GlobalData Terms & Conditions. Content in the dashboard should not be viewed as a recommendation and should not be relied upon to make investment decisions. We make every effort to ensure our content is accurate and to correct mistakes as soon as possible. If you spot an error please email editorialenquiries@globaldata.com. Further information about our editorial standards and complaints procedure is available here. GlobalData is not responsible for the use of any content outside the scope of the GlobalData Terms & Conditions.
Latest News
View More
Stryker launches Q Guidance System with Spine Guidance Software
Michigan, US-based medical technology company Stryker has announced the launch of its Q Guidance System with Spine Guidance Software for spine applications. To provide increased…
Mesh Suture receives approval for non-absorbable polypropylene mesh suture
Mesh Suture, which does business as MSi, has secured 510(k) approval from the US Food and Drug Administration (FDA) for…
NeuroCatch gains Health Canada approval for improved portable brain scanner
HealthTech Connex’s subsidiary NeuroCatch has secured a medical device licence from Health Canada for the latest version of its NeuroCatch…
Enzo Biochem introduces RNA gene expression platform
Biosciences and diagnostics company Enzo Biochem has launched a new RNA gene expression platform called AMPIVIEW. Powered by the firm’s…
Pulse Biosciences receives FDA 510(k) approval for CellFX system
Bioelectric medicine company Pulse Biosciences has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its CellFX…
